|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K | (2006.01) |
| A61K 31/415 | (2006.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61K 31/44 | (2006.01) | ||
| A61K 31/5025 | (2006.01) | ||
| A61K 31/505 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61K 31/5517 | (2006.01) | ||
| A61P | (2006.01) | ||
| A61P 7/02 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| C07D | (2006.01) | ||
| C07D 471/04 | (2006.01) | ||
| C07D 487/04 | (2006.01) |
| (11) | Number of the document | 1140941 |
| (13) | Kind of document | T |
| (96) | European patent application number | 99967444.3 |
| Date of filing the European patent application | 1999-12-17 | |
| (97) | Date of publication of the European application | 2001-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2004-10-20 |
| (46) | Date of publication of the claims translation | 2005-02-25 |
| (86) | Number | PCT/US1999/030316 |
| Date | 1999-12-17 |
| (87) | Number | WO 2000/039131 |
| Date | 2000-07-06 |
| (30) | Number | Date | Country code |
| 113628 P | 1998-12-23 | US | |
| 127633 P | 1999-04-02 | US |
| (72) |
FEVIG, John, M., US
CACCIOLA, Joseph, US
CLARK, Charles, G., US
LAM, Patrick, Yuk, Sun, US
PINTO, Donald, J., P., US
PRUITT, James, R., US
ROSSI, Karen, A., US
|
| (73) |
Bristol-Myers Squibb Holdings Ireland Unlimited Company,
Hinterbergstrasse 16, 6312 Steinhausen,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Azotą turintys heterobiciklai kaip XA faktoriaus inhibitoriai |
| NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2018-11-26 | 20 | 347.00 EUR |